The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patients with radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) with BRAF V600E and/or K601E mutation status: A real-world view of effectiveness of lenvatinib monotherapy.
 
Francis P. Worden
Honoraria - Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Merck Sharp & Dohme; Regeneron
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; eisai; Exelixis; Loxo; Merck; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Eisai (Inst); Lilly (Inst); Loxo/Lilly (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Sharp & Dohme
 
Lori J. Wirth
Consulting or Advisory Role - Bayer; Coherus Biosciences; Curie Therapeutics; Eisai; Exelixis; Lilly; Merck; METIS Precision Medicine; Morphic Therapeutic; Tome Biosciences
Research Funding - Checkmate Pharmaceuticals (Inst); Eisai (Inst); Lilly (Inst); Novartis (Inst)
Expert Testimony - Eisai
Other Relationship - PDS Biotechnology
 
Neil Reynolds
Research Funding - ABBVIE/ABBOTT (Inst); BMSi (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Novo Nordisk (Inst); Pfizer (Inst); Takeda (Inst); ViiV Healthcare (Inst)
 
Charley Cooper
Research Funding - AstraZeneca (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Merck (Inst); Novo Nordisk (Inst); Pfizer (Inst)
 
Olivera Rajkovic-Hooley
Research Funding - ABBVIE/ABBOTT (Inst); Amgen (Inst); AstraZeneca (Inst); BMSi (Inst); Eisai (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); Novo Nordisk (Inst)
 
Gary Milligan
Employment - Adelphi
 
Phananh Pham
Employment - Eisai
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - Eisai
 
Hakim Saal
Employment - Eisai
Travel, Accommodations, Expenses - Eisai
 
Marcia S. Brose
Honoraria - Bayer; Eisai; Lilly
Consulting or Advisory Role - AADi; Bayer; Eisai; Exelixis; Lilly; Loxo
Research Funding - Lilly (Inst); Loxo (Inst)